144 related articles for article (PubMed ID: 35537246)
21. Conventional 99mTc-(hydroxy) methylene diphosphate remains useful to predict osteosarcoma response to neoadjuvant chemotherapy: Individual patient data and aggregate data meta-analyses.
Kubo T; Furuta T; Sakuda T; Ochi M; Adachi N
Medicine (Baltimore); 2018 Dec; 97(51):e13308. PubMed ID: 30572434
[TBL] [Abstract][Full Text] [Related]
22. Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.
Jeon DG; Song WS; Cho WH; Kong CB; Cho SH
Clin Orthop Relat Res; 2014 Jun; 472(6):1911-20. PubMed ID: 24574120
[TBL] [Abstract][Full Text] [Related]
23. T1 mapping as a surrogate marker of chemotherapy response evaluation in patients with osteosarcoma.
Baidya Kayal E; Sharma N; Sharma R; Bakhshi S; Kandasamy D; Mehndiratta A
Eur J Radiol; 2022 Mar; 148():110170. PubMed ID: 35086004
[TBL] [Abstract][Full Text] [Related]
24. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma.
Lin J; Leung WT; Ho SK; Ho KC; Kumta SM; Metreweli C; Johnson PJ
Eur J Nucl Med; 1995 Jun; 22(6):553-5. PubMed ID: 7556302
[TBL] [Abstract][Full Text] [Related]
25. [Prediction of chemotherapy response in primary osteosarcoma using the machine learning technique on radiomic data].
Dufau J; Bouhamama A; Leporq B; Malaureille L; Beuf O; Gouin F; Pilleul F; Marec-Berard P
Bull Cancer; 2019 Nov; 106(11):983-999. PubMed ID: 31587802
[TBL] [Abstract][Full Text] [Related]
26. Monitoring Response to Neoadjuvant Chemotherapy of Primary Osteosarcoma Using Diffusion Kurtosis Magnetic Resonance Imaging: Initial Findings.
Liu C; Xi Y; Li M; Jiao Q; Zhang H; Yang Q; Yao W
Korean J Radiol; 2019 May; 20(5):801-811. PubMed ID: 30993931
[TBL] [Abstract][Full Text] [Related]
27. The current status of MRI in the pre-operative assessment of intramedullary conventional appendicular osteosarcoma.
Saifuddin A; Sharif B; Gerrand C; Whelan J
Skeletal Radiol; 2019 Apr; 48(4):503-516. PubMed ID: 30288560
[TBL] [Abstract][Full Text] [Related]
28. Texture analysis for chemotherapy response evaluation in osteosarcoma using MR imaging.
Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
NMR Biomed; 2021 Feb; 34(2):e4426. PubMed ID: 33078438
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a model.
Kalisvaart GM; Van Den Berghe T; Grootjans W; Lejoly M; Huysse WCJ; Bovée JVMG; Creytens D; Gelderblom H; Speetjens FM; Lapeire L; van de Sande MAJ; Sys G; de Geus-Oei LF; Verstraete KL; Bloem JL
Skeletal Radiol; 2024 Feb; 53(2):319-328. PubMed ID: 37464020
[TBL] [Abstract][Full Text] [Related]
30. [The value of computed tomography in monitoring the preoperative chemotherapy of osteosarcoma].
Rotte KH; Kriedemann E; Geyer J; Kunde D; Melcher J; Perlick E; Schmidt-Peter P
Rofo; 1989 Jan; 150(1):8-12. PubMed ID: 2536502
[TBL] [Abstract][Full Text] [Related]
31. MRI Identification of the Osseous Extent of Pediatric Bone Sarcomas.
Thompson MJ; Shapton JC; Punt SE; Johnson CN; Conrad EU
Clin Orthop Relat Res; 2018 Mar; 476(3):559-564. PubMed ID: 29529641
[TBL] [Abstract][Full Text] [Related]
32. Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy.
Wang J; Sun M; Liu D; Hu X; Pui MH; Meng Q; Gao Z
Acta Radiol; 2017 Aug; 58(8):971-976. PubMed ID: 27852643
[TBL] [Abstract][Full Text] [Related]
33. Transepiphyseal resection for osteosarcoma in patients with open physes using MRI assessment.
Kim Y; Jang WY; Park JW; Park YK; Cho HS; Han I; Kim HS
Bone Joint J; 2020 Jun; 102-B(6):772-778. PubMed ID: 32475249
[TBL] [Abstract][Full Text] [Related]
34. The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy.
Punyaratabandhu T; Wittayawongsaruji S; Rajchadara S; Thanakit V; Charoenvareekul S; Khunkitti N; Songpatanasilp T
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S53-62. PubMed ID: 16862675
[TBL] [Abstract][Full Text] [Related]
35. Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma.
Imbriaco M; Yeh SD; Yeung H; Zhang JJ; Healey JH; Meyers P; Huvos AG; Larson SM
Cancer; 1997 Oct; 80(8):1507-12. PubMed ID: 9338476
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of static and dynamic MRI for assessing response of bone sarcomas to preoperative chemotherapy: Correlation with histological necrosis.
Amit P; Malhotra A; Kumar R; Kumar L; Patro DK; Elangovan S
Indian J Radiol Imaging; 2015; 25(3):269-75. PubMed ID: 26288521
[TBL] [Abstract][Full Text] [Related]
37. Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma.
Tsuda Y; Tsoi K; Parry MC; Stevenson JD; Fujiwara T; Sumathi V; Jeys LM
Bone Joint J; 2020 Jun; 102-B(6):795-803. PubMed ID: 32475245
[TBL] [Abstract][Full Text] [Related]
38. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
39. Tumor-to-background ratio to predict response to chemotherapy of osteosarcoma better than standard uptake values.
He JP; Hao Y; Li M; Wang J; Guo FJ
Orthop Surg; 2014 May; 6(2):145-53. PubMed ID: 24890297
[TBL] [Abstract][Full Text] [Related]
40. SLIC-supervoxels-based response evaluation of osteosarcoma treated with neoadjuvant chemotherapy using multi-parametric MR imaging.
Baidya Kayal E; Kandasamy D; Sharma R; Sharma MC; Bakhshi S; Mehndiratta A
Eur Radiol; 2020 Jun; 30(6):3125-3136. PubMed ID: 32086578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]